Evidence map›Paper›PMID 32849644›Full record

ArticleFrontiers in immunology2020

The Generation of an Engineered Interleukin-10 Protein With Improved Stability and Biological Function.

Faisal Minshawi, Sebastian Lanvermann, Edward McKenzie, Rebecca Jeffery, Kevin Couper, Stamatia Papoutsopoulou, Axel Roers, Werner Muller

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Genetic polymorphisms and protein levels in vocal fold leukoplakia: a systematic review.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Armored human CAR TScience advances · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Faisal MinshawiDepartment of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.
Sebastian LanvermannCentre for Translational Medicine, Thomas Jefferson University, Philadelphia, PA, United States.
Edward McKenzieManchester Institute of Biotechnology, Faculty of Science and Engineering, University of Manchester, Manchester, United Kingdom.
Rebecca JefferyLydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, United Kingdom.
Kevin CouperLydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, United Kingdom.
Stamatia PapoutsopoulouLydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, United Kingdom.
Axel RoersInstitute of Immunology, Medical Faculty Carl Gustav Carus, University of Technology Dresden, Dresden, Germany.
Werner MullerLydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, United Kingdom.
University of Manchester · GBThomas Jefferson University · USUmm al-Qura University · SAUniversity Hospital Carl Gustav Carus · DEUniversity of Liverpool · GB

Funding

Medical Research Council MR/R010099/1
6 · The paper itself

Abstract

Interleukin-10 (IL-10) is an immunoregulatory cytokine that plays a pivotal role in modulating inflammation. IL-10 has inhibitory effects on proinflammatory cytokine production and function

Indexed as

AnimalsHumansInterleukin-10MiceProtein EngineeringProtein StabilityInterleukin-10covalent linkercytokineimmunoregulationinflammationinterleukin-10stable dimer

Identifiers

PMID32849644
PMCPMC7431522
OpenAlexW3044114013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.